A new class of protein therapies

GRO Biosciences

Background GRO Biosciences
GRO Biosciences Dan Mandell, CEO of GRO Biosciences

GRO Biosciences is leveraging breakthrough technologies from computational protein design and synthetic biology to develop best-in-class protein therapeutics for diabetes, growth disorders and autoimmunity. The company was co-founded by Dr. George Church.


Digitalis, Innovation Endeavors, Leaps by Bayer

University Spinout